Actively Recruiting

Age: 18Years +
FEMALE
NCT05914974

Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies

Led by University Hospital Tuebingen · Updated on 2026-02-10

120

Participants Needed

1

Research Sites

602 weeks

Total Duration

On this page

Sponsors

U

University Hospital Tuebingen

Lead Sponsor

U

University Hospital Ulm

Collaborating Sponsor

AI-Summary

What this Trial Is About

ICK-Gyn is a prospective, multicentric, non-interventional investigator-initiated trial (IIT) that aims to investigate the prognostic value of CRP kinetics in advanced or metastatic gynecological malignancies under immune checkpoint inhibitor (ICI) therapy on the objective response rate (ORR), progression-free survival (PFS) and overall survival (OS).

CONDITIONS

Official Title

Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women 18 years of age or older
  • Histologically confirmed metastatic gynecological malignancies regardless of therapy line
  • Eligibility for immune checkpoint inhibitor (ICI) therapy in the experimental group
  • Planned ICI therapy combined with palliative chemotherapy in the experimental group
  • Receiving chemotherapy without ICIs as first therapy line in the control group
  • Provided written informed consent to participate in ICK-Gyn
Not Eligible

You will not qualify if you...

  • No indication for ICI therapy in the experimental group
  • Prior ICI therapy before enrollment
  • Advanced or metastatic endometrial or cervical cancer in second or later therapy line without ICI indication
  • Pregnant or lactating women
  • Poor general health condition not suitable for chemotherapy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Women's Health

Tübingen, Germany, 72076

Actively Recruiting

Loading map...

Research Team

D

Dominik Dannehl, Dr.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies | DecenTrialz